BloodWork,
#PTCL has poor outcomes but in the 1/3 who remain event free at 2 yrs (EFS24) @JCO_ASCO shows half may be 'cured' (C
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
Overview of attention for article published in Journal of Clinical Oncology, October 2017
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
Good Attention Score compared to outputs of the same age and source (68th percentile)
Mentioned by
- news
- 3 news outlets
- policy
- 1 policy source
- 25 X users
- patent
- 2 patents
- 1 Facebook page
- wikipedia
- 1 Wikipedia page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 49 Mendeley